Leef Brands (LEEEF) Current Assets (2024 - 2026)

Leef Brands (LEEEF) posted Current Assets of $13.7 million for Q1 2026, up 68.61% sequentially from $8.1 million in Q4 2025.

Leef Brands (LEEEF) Current Assets (2024 - 2026) Analysis & Trends

Leef Brands has reported Current Assets for 3 years, with the latest figure at $13.7 million in Q1 2026.

Quarterly Current Assets changed N/A year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (changed N/A YoY) and the FY2025 annual result came in at $8.1 million, down 22.23% from the prior year.
Current Assets improved to $13.7 million in Q1 2026 per LEEEF's latest filing, from $8.1 million in the prior quarter.
Over five years, Current Assets peaked at $13.7 million in Q1 2026 and troughed at $8.1 million in Q4 2025.
A 3-year average of $10.8 million and a median of $10.5 million in 2024 frame the typical range for Current Assets.
The widest YoY moves for Current Assets: up 22.23% in 2025, down 22.23% in 2025.
Over 3 years, Current Assets stood at $10.5 million in 2024, then retreated by 22.23% to $8.1 million in 2025, then surged by 68.61% to $13.7 million in 2026.
According to Business Quant data, Current Assets over the past three periods registered $13.7 million, $8.1 million, and $10.5 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Assets (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	5.76 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	13.76 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	6.36 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	19.76 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	3.48 Bn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	10.06 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	1.64 Bn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	3.80 Bn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	3.22 Bn
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn	16.37 Mn

Download Data